RxDoctor Payments Data

Ardeshir Ebn Alnassir

Physician Assistant · Tustin, CANPI 1134652241

Payments from drug & device makers

$5,997in general payments, 2019–2025

Across 216 payments — averaging $27.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Lilly USA, LLC$976
  • Johnson & Johnson$644
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$589
  • Bayer$271
  • AstraZeneca$257
  • plus $2K from 26 others

What the payments were for

  • Food & beverage$5,997100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,997 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide25$31,761
MounjaroTirzepatide14$20,590
JardianceEmpagliflozin19$20,367
XareltoRivaroxaban11$17,613
TrulicityDulaglutide12$14,353
Rufinamide13$12,178
EliquisApixaban11$12,125
Diclofenac Sodium26$8,079
Breo ElliptaFluticasone/Vilanterol12$5,241
Lubiprostone15$3,506
Levothyroxine Sodium60$1,552
Rosuvastatin Calcium81$1,532
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,505
Nano 2nd Gen Pen NeedlePen Needle, Diabetic11$818
Duloxetine Hcl16$707

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$976$34,94426 claims
Novo NordiskOzempic$1,146$31,76125 claims
Boehringer IngelheimJardiance$237$20,36719 claims
Johnson & JohnsonXarelto$644$17,61311 claims
PfizerEliquis$174$12,12511 claims
GSKBreo Ellipta$109$5,24112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Tustin

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →